ArticleMolecular genetics & genomic medicine2026
Multi-Level Genomic and Computational Analyses Identify a Novel IFT122 Variant Associated With Cranioectodermal Dysplasia 1 in a Consanguineous Saudi Family.
Article in Molecular genetics & genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCranioectodermal dysplasia (CED) is a rare autosomal recessive ciliopathy characterized by craniofacial, skeletal, and ectodermal anomalies. Significant phenotypic heterogeneity often results in clinical overlap with other skeletal dysplasias, including Robinow syndrome. In consanguineous populations, the presence of multiple rare variants can further complicate the molecular diagnosis. This study aimed to clarify the genetic basis of a complex syndromic presentation in a consanguineous Saudi family exhibiting features suggestive of both disorders using an integrated phenotypic, genomic, and computational approach.
methodsExome sequencing was performed on two affected siblings, followed by Sanger sequencing for the familial segregation analysis. Detailed phenotypic evaluation was combined with structural and bioinformatics analyses, including in silico pathogenicity prediction tools, three-dimensional protein modeling, protein-protein interaction analysis, and molecular docking to assess the structural and functional impact of candidate variants.
resultsExome sequencing identified a homozygous missense variant in IFT122 gene (c.94G > A; p.Gly32Arg), associated with cranioectodermal dysplasia 1, and a heterozygous frameshift variant in DVL3 gene (c.1949_1950del; p.His650Profs*60), associated with Robinow syndrome. Segregation analysis excluded the DVL3 variant as the primary cause, while the IFT122 variant segregated with the phenotype in an autosomal recessive manner. Computational analyses demonstrated that the p.Gly32Arg substitution affects a highly conserved residue and is consistently predicted to be deleterious. Structural modeling revealed the disruption of local hydrogen bonding, increased solvent accessibility, and reduced protein stability. Protein-protein interaction and molecular docking analyses further indicated altered interactions with key IFT-A components, including TTC21B, IFT140, TULP3, and IFT43, suggesting impaired intraflagellar transport complex integrity and ciliary protein trafficking.
conclusionThis study identifies a novel homozygous IFT122 (c.94G > A; p.Gly32Arg) variant underlying CED1, thereby expanding the molecular spectrum of IFT122-related ciliopathies. These findings emphasize the value of integrating phenotypic, genomic, segregation, and structural analyses to resolve diagnostically challenging cases, particularly in consanguineous populations. Further functional studies are warranted to confirm this molecular mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.